Monoclonal Ab Flashcards
1
Q
Nivolumab , tremelizumab
A
Nsclc, melanoma, H.L
2
Q
Durvalumab
A
Endometrial ca
3
Q
Atezolizumab
Avelumab
A
Urothelial ca
4
Q
Ipilimumab cepicimumab
A
Nsclc, melanoma
5
Q
Pembrolizumab
A
P pulm ca
E endometrial ca
M melanoma
B brca
O oesophageal and stomach
L lynch syn
I intestine CRC
Z H nd neck
U urothelial + genital
M merkel cell , mediastinal
A abn microsatellite instability
B b cell large
6
Q
Almetuzumab
A
Cd 52
Cll , MS
7
Q
Dinu tu ximab
Naxitamab
A
Gd2
Neuroblastoma in children
8
Q
What are the 3 immune check point inhibitors
A
Pd -L-1
Ctla4r
Pd1r
9
Q
Pd-l-1
A
Produced by APC
Atezolizumab
Avelumab
Durvalumab
10
Q
CTLA4R
A
By b7 ag of wbc
IPILIMUMAB
TREMELIMUMAB
11
Q
Pd1r
A
On wbc
Nivolumab
Cepilimumab
Pembrolizumab
12
Q
A
